X-ray Structure of Human Gankyrin, the Product of a Gene Linked to Hepatocellular Carcinoma

Proteins: Structure, Function and Genetics

Volumn 55, Issue 1, 2004, Pages 214-217

  Manjasetty, Babu A ^a,b,g   Quedenau, Claudia ^c,d   Sievert, Volker ^c,d   Büssow, Konrad ^c,d   Niesen, Frank ^c,e   Delbrück, Heinrich ^c,f   Heinemann, Udo ^b,f  

^a HAHN MEITNER INSTITUT   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Protein Structure Factory   (Germany)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

^g GOVERNMENT SCIENCE COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GANKYRIN; GENE PRODUCT; ONCOPROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CRYSTALLIZATION; GENETIC LINKAGE; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; X RAY ANALYSIS;

AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CRYSTALLOGRAPHY, X-RAY; HUMANS; LIVER NEOPLASMS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SEQUENCE ALIGNMENT;

EID: 1442275579     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.20028     Document Type: Article

References (32)

1. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S, Fujita, J. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 2000;6:96-99.
2. Dawson S, Apcher S, Mee M, Higashitsuji H, Baker R, Uhle S, Dubiel W, Fujita J, Mayer RJ. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. J Biol Chem 2002;277:10893-10902.
3. Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, Mayer RJ, Itoh K, Fujita J. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 278;2003:10668-10674.
4. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646.
5. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
6. Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 1998:391;859-865.
7. Kim HY, Ahn BY, Cho Y. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J 2001:20;295-304.
8. Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 1997;173:233-236.
9. Li J, Tsai MD. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 2002;41:3977-3983.
10. Barker PA, Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 2002;67:705-712.
11. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001;61:5544-5551.
12. Dawson S, Hastings R, Takayanagi K, Reynolds S, Low P, Billett M, Mayer RJ. The 26S-proteasome: Regulation and substrate recognition. Mol Biol Rep 24;1997:39-44.
13. Krzywda S, Brzozowski AM, Al-Safty R, Welchman R, Mee M, Dawson S, Fujita J, Higashitsuji H, Mayer RJ, Wilkinson AJ. Crystallization of gankyrin, an oncoprotein that interacts with CDK4 and the S6b (rpt3) ATPase of the 19S regulator of the 26S proteasome. Acta Crystallogr D 2003;59:1294-1295.
14. Adachi N, Padmanabhan B, Kataoka K, Kijima K, Yamaki M, Horikoshi M. Purification, crystallization and preliminary X-ray diffraction analysis of yeast regulatory particle non-ATPase subunit 6 (Nas6p). Acta Crystallogr D 2002;58:859-860.
15. Heinemann U, Büssow K, Mueller U, Umbach P. Facilities and methods for the high-throughput crystal structural analysis of human proteins. Acc Chem Res 2003;36:157-163.
16. INK4A: Determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol Cell 1998;1:421-431.
17. INK4a. Nature 1998;395:237-243.
18. Jeffrey PD, Tong L, Pavletich NP. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev 2000;14:3115-3125.
19. Mueller U, Nyarsik L, Horn M, Rauth H, Przewieslik T, Saenger W, Lehrach H, Eickhoff H. Development of a technology for automation and miniaturisation of protein crystallisation. J Biotechnol 2001;85:7-14.
20. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997;276:307-326.
21. Vagin A, Teplyakov A. An approach to multi-copy search in molecular replacement. Acta Crystallogr D 2000;56;1622-1624.
22. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003;31:3381-3385.
23. Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 1997;53:240-255.
24. Terwilliger TC. Map-likelihood phasing. Acta Crystallogr D 2001;57:1763-1775.
25. Perrakis A, Harkiolaki M, Wilson KS, Lamzin VS. ARP/wARP and molecular replacement. Acta Crystallogr D 2001;57:1445-1450.
26. Winn MD, Isupov MN, Murshudov GN. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D 2001;57:122-133.
27. Kraulis P. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 1991;24:946-950.
28. Esnouf RM. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr D 1999;55:938-940.
29. Merritt EA, Murphy MEP. Raster3d version 2.0-a program for photorealistic molecular graphics. Acta Crystallogr D 1994;50:869-873.
30. Michaely P, Tomchick DR, Machius M, Anderson RGW. Crystal structure of a 12 ANK repeat stack from human ankyrinR. EMBO J 2002;21:6387-6396.
31. Krzywda S, Brzozowski AM, Higashitsuji H, Fujita J, Welchman R, Dawson S, Mayer RJ, Wilkinson AJ. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal regulator, and the tumor suppressors Rb and p53. J Biol Chem 2004;279:1541-1545.
32. Padmanabhan B, Adachi N, Kataoka K, Horikoshi M. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6. J Biol Chem 2004;279:1546-1552.